Navellier & Associates’s Phibro Animal Health PAHC Stock Holding History

Navellier & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,340	Closed	-$2.89M	–	372
2026 Q1	$2.89M	Buy	52,340 +5,068	+11%	+$241K	0.3%	79
2025 Q4	$1.77M	Sell	47,272 -4,354	-8%	-$177K	0.2%	110
2025 Q3	$2.09M	Buy	51,626 +7,855	+18%	+$259K	0.21%	109
2025 Q2	$1.12M	Sell	43,771 -1,172	-3%	-$25.6K	0.14%	129
2025 Q1	$878K	Buy	+44,943	New	+$1M	0.12%	147
2015 Q3	–	Sell	-7,000	Closed	-$273K	–	365
2015 Q2	$273K	Buy	+7,000	New	+$241K	0.02%	296

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Navellier & Associates's PAHC Position: Q2 2026 in Review

Navellier & Associates sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 52,340 shares — an estimated $2.89M sold.

Navellier & Associates first reported a position in PAHC in Q2 2015 and held it in 6 quarters. The position peaked at $2.89M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Navellier & Associates reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
Navellier & Associates sold 52,340 Phibro Animal Health shares in Q2 2026, an estimated $2.89M.
Navellier & Associates first reported a position in Phibro Animal Health in Q2 2015 and held it in 6 quarters.
Navellier & Associates's Phibro Animal Health position peaked at $2.89M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.